SA
Syntax Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $236K | Sell |
678
-12
| -2% | -$4.17K | 0.21% | 124 |
|
|
2023
Q2 | $243K | Sell |
690
-145
| -17% | -$51K | 0.2% | 135 |
|
|
2023
Q1 | $263K | Buy |
835
+63
| +8% | +$19.8K | 0.2% | 123 |
|
|
2022
Q4 | $223K | Sell |
772
-103
| -12% | -$29.7K | 0.19% | 163 |
|
|
2022
Q3 | $253K | Sell |
875
-70
| -7% | -$20.2K | 0.22% | 103 |
|
|
2022
Q2 | $266K | Sell |
945
-27
| -3% | -$7.6K | 0.22% | 96 |
|
|
2022
Q1 | $254K | Sell |
972
-280
| -22% | -$73.2K | 0.21% | 129 |
|
|
2021
Q4 | $275K | Buy |
+1,252
| New | +$275K | 0.2% | 141 |
|